The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
Open accessAbstract
The dominant TLR5(R392X) polymorphism abrogates flagellin responses in >7% of humans. We report that TLR5-dependent commensal bacteria drive malignant progression at extramucosal locations by increasing systemic IL-6, which drives mobilization of myeloid-derived suppressor cells (MDSCs). Mechanistically, expanded granulocytic MDSCs cause γδ lymphocytes in TLR5-responsive tumors to secrete galectin-1, dampening antitumor immunity and accelerating malignant progression. In contrast, IL-17 is consistently upregulated in TLR5-unresponsive tumor-bearing mice but only accelerates malignant progression in IL-6-unresponsive tumors. Importantly, depletion of commensal bacteria abrogates TLR5-dependent differences in tumor growth. Contrasting differences in inflammatory cytokines and malignant evolution are recapitulated in TLR5-responsive/unresponsive ovarian and breast cancer patients. Therefore, inflammation, antitumor immunity, and the clinical outcome of cancer patients are influenced by a common TLR5 polymorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the natural immunosurveillance of cancers can be negatively impacted by gut commensals through TLR5- and IL-6-dependent inflammation.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [36]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [29]
In the citing paper
“The interaction resulted in IL-6-dependent mobilization of MDSCs and subsequently more γδT cells producing immunosuppressive galectin-1, followed by impaired antitumor response and accelerated malignant progression [60] (Fig. 2).”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [60]
In the citing paper
“The notion was further supported by another study showing bacterial flagellin stimulated pro-tumoral inflammation through TLR5 signaling [60].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., & Weiser, J. N. (2010) · Nature Medicine · doi:10.1038/nm.2087 · Cited by 1,154
Jonkers, J., Meuwissen, R. L. J., van der Gulden, H. M. L., Peterse, H. L., van der Valk, M., & Berns, A. J. M. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,044
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 868
Kryczek, I., Banerjee, M., Cheng, P. J., Vatan, L., Szeliga, W., Wei, S., Huang, E. H., Finlayson, E. V. A., Simeone, D. M., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 852
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653
Self-citation
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 311
Hooper, M. J., LeWitt, T. M., Pang, Y., Veon, F. L., Chlipala, G. E., Feferman, L., Green, S. J., Sweeney, D., Bagnowski, K., Burns, M. B., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18125 · Cited by 16
Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy
Sabeel, Z., & Zhao, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02456-x · Cited by 17
Croci, D. O., Méndez‐Huergo, S. P., Cerliani, J. P., & Rabinovich, G. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_29 · Cited by 14
Self-citationMa, A., Fan, D., & Yan, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9250 · Cited by 14
Rutkowski, M. R., & Conejo-Garcia, J. R. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1021542 · Cited by 14
Self-citationIL-17A-producing γδ T cells promote liver pathology in acute murine schistosomiasis
Sun, L., Gong, W., Shen, Y., Liang, L., Zhang, X., Li, T., Chen, T. T., Hu, Y., & Cao, J. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04200-4 · Cited by 15
Wang, X., Zheng, Y., Chen, X., Chen, P., Zhou, S., Shen, S., Zhao, S., & Wang, T. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1231354 · Cited by 13
Lifestyle and Breast Cancer: Prevention and Treatment Support
Ratajczak, A. E., Jezierska, K., Szymczak‐Tomczak, A., Zawada, A. E., Rychter, A. M., Skoracka, K., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2025) · Cancers · doi:10.3390/cancers17172830 · Cited by 12
Papa‐Gobbi, R., Muglia, C. I., Rocca, A., Curciarello, R., Sambuelli, A. M., Yantorno, M., Correa, G. J., Morosi, L. G., Sabatino, A. D., Biancheri, P., et al. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01675-z · Cited by 10
Self-citationNutrition and Diet Patterns as Key Modulators of Metabolic Reprogramming in Melanoma Immunotherapy
Grafanaki, K., Maniatis, A., Anastogianni, A., Bania, A., Pasmatzi, E., & Stathopoulos, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124193 · Cited by 12
Gut–Vaginal Microbiome Crosstalk in Ovarian Cancer: Implications for Early Diagnosis
Zhang, H., Lin, H., Zeng, Z., Jia, Y., Zhang, H., Pang, J. M., & Chen, J. J. (2025) · Pathogens · doi:10.3390/pathogens14070635 · Cited by 11
Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature
Clanton, R., Saucier, D., Ford, J. R., & Akabani, G. (2015) · Environmental Research · doi:10.1016/j.envres.2015.06.026 · Cited by 12
Galectins: Key Players at the Frontiers of Innate and Adaptive Immunity
Allo, V. C. M., Toscano, M. A., Pinto, N. A., & Rabinovich, G. A. (2018) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1740.1se · Cited by 11
Self-citationActis, S., Cazzaniga, M., Bounous, V. E., D’Alonzo, M., Rosso, R., Accomasso, F., Minella, C., & Biglia, N. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad071 · Cited by 10
Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas
Gumina, M. E., Hooper, M. J., Zhou, X. A., & Koralov, S. B. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.10.023 · Cited by 10
Signal‐transducing innate receptors in tumor immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2021) · Cancer Science · doi:10.1111/cas.14848 · Cited by 12
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
L'Orphelin, J. ‐., Dompmartin, A., & Dréno, B. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13224 · Cited by 11
Blanco, J. R., del Campo, R., Ortiz, J. A., Olmos, M. L., & Carnero, A. (2025) · Cells · doi:10.3390/cells14221813 · Cited by 14
Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer
Shi, L., Xu, Y., & Feng, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07689-0 · Cited by 9
Rutkowski, M. R., & Conejo-Garcia, J. R. (2015) · Oncoscience · doi:10.18632/oncoscience.145 · Cited by 9
Self-citationRôle du microbiote intestinal dans la réponse aux thérapies anti-tumorales
Vétizou, M., Daillère, R., & Zitvogel, L. (2017) · Biologie Aujourd hui · doi:10.1051/jbio/2017009 · Cited by 9
Therapeutic Strategies for Breast Cancer
Makhoul, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00024-6 · Cited by 9
Hu, C., Liu, H., Pang, B., Wu, H., Lin, X., Yu, Z., & Yi, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16651 · Cited by 10
The duplexity of unconventional T cells in cancer
Lawrence, M. D., Wiesheu, R., & Coffelt, S. B. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106213 · Cited by 9
Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier
Wang, S., Li, S., Zhang, M., Liu, R., Ye, X., Mao, S., Yu, J., Xie, X., & Tan, W. (2025) · Research · doi:10.34133/research.0744 · Cited by 11
Contribution of the Gut and Vaginal Microbiomes to Gynecological Cancers
Jayshree, R. S., & Kumar, R. V. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_31 · Cited by 7
Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors
Barsac, E., Herbozo, C. D. A., Gonzalez, L., Baranek, T., Mallevaey, T., & Paget, C. (2021) · Cancers · doi:10.3390/cancers13143578 · Cited by 8
Innovative Therapy, Monoclonal Antibodies and Beyond
Nicola, M. D., Apétoh, L., Bellone, M., Colombo, M. P., Dotti, G., Ferrone, S., Muscolini, M., Hiscott, J. B., Anichini, A., Pupa, S. M., et al. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.10.002 · Cited by 8
Cellular Immunity in Obesity: Pathophysiological Insights and the Impact of Bariatric Surgery
Rivera-Carranza, T., Girón, A. L.-T., Gónzalez-Vázquez, R., Vázquez-Cárdenas, P., Esquivel-Campos, A. L., Mendoza‐Pérez, F., Rojano‐Rodriguez, M., Mimiaga-Hernández, C., Cifuentes-Goches, J. C., Valle, O. E. P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209867 · Cited by 7
γδ T Cells for Cancer Immunotherapy: Unconventional Players Take the Spotlight
Stevens, G., Blanco-Domínguez, R., Mensurado, S., & Silva‐Santos, B. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-024653 · Cited by 8
Role of microbiota in radiation-induced small-bowel damage
Chen, Y., Li, S., & Huang, E. (2023) · Journal of Radiation Research · doi:10.1093/jrr/rrad084 · Cited by 7
Pro‐ and antitumorigenic functions of γδ T cells
Fiala, G. J., Lücke, J., & Huber, S. (2024) · European Journal of Immunology · doi:10.1002/eji.202451070 · Cited by 7
McGinty, M. T., Putelo, A. M., Kolli, S. H., Feng, T.-Y., Dietl, M. R., Hatzinger, C. N., Bajgai, S., Poblete, M. K., Azar, F. N., Mohammad, A., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0513 · Cited by 7
Self-citationLi, X., Chen, Y., Liang, Y., & Shi, W. (2024) · BMC Cancer · doi:10.1186/s12885-024-12742-4 · Cited by 6
Royse, K. E., Liang, C., Berger, D. H., Ittmann, M., El‐Serag, H. B., Balentine, C. J., Graham, D. Y., Richardson, P., Rumbaut, R. E., Shen, X. Y., et al. (2017) · PubMed Central · Cited by 6
γδ T cells share the spotlight in cancer
Conejo-Garcia, J. R., & Innamarato, P. (2022) · Nature Cancer · doi:10.1038/s43018-022-00396-9 · Cited by 6
Self-citationThe role of γδ T cells and CAR-γδ T cell therapy in autoimmune diseases
Wang, T., Wang, H., Lv, R., Wen, C., Wang, M., & Huang, L. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103883 · Cited by 5
Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
Luo, H.-Y., Cao, L., Zhou, K., Xiao, Y., Li, Z., Liu, B., & Bu, L. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.08.001 · Cited by 6
Toll-like receptor agonists as cancer therapeutics: a patent review (2014–2024)
Kumar, P., Zargar, Z. B., Chopra, K., Pawar, S. V., & Salunke, D. B. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2556819 · Cited by 5
Jiang, L., Li, M., & Zhao, Z. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf230 · Cited by 5
The Impact of Microbiome on Breast Cancer and Regulatory Strategies
Wang, J., Xu, D., Hu, S., Zheng, B., Chen, Y., & Pan, T. (2025) · Microorganisms · doi:10.3390/microorganisms14010075 · Cited by 5
Gut microbiota drives cancer evolution and therapy resistance
Min, S., Zhang, Y., Zhang, H., & Liu, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02564-8 · Cited by 8
Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis
Babay, W., Garci, M., Laaribi, A. B., Mathlouthi, N., & Ouzari, H. (2026) · Immunology · doi:10.1111/imm.70112 · Cited by 6
Li, S., Liu, R., Hao, X., & Liu, X. (2024) · Medicine · doi:10.1097/md.0000000000038825 · Cited by 7
Role of Toll like Receptor(s) in Tumor Biology
Gupta, D. (2017) · Journal of Tumor Medicine & Prevention · doi:10.19080/jtmp.2017.01.555554 · Cited by 6
Possible Prophylaxes of Aloe Vera Gel Ingestion to Butyrate Metabolism
Yagi, A., Kabbash, A. M., & Al-Madboly, L. A. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.665 · Cited by 4
The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer
Bonvalet, M., Daillère, R., Roberti, M. P., Rauber, C., & Zitvogel, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_27 · Cited by 4
The microbiome and ovarian cancer: insights, implications, and therapeutic opportunities
Mehra, Y., Chalif, J., Mensah-Bonsu, C., Spakowicz, D. J., O’Malley, D. M., & Chambers, L. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.107 · Cited by 4
The Tight Relationship Between the Tumoral Microenvironment and Radium-223
Conte, M., Tomaciello, M., Feo, M. S. D., Frantellizzi, V., Marampon, F., Cristofaro, F. D., Vincentis, G. D., & Filippi, L. (2025) · Biomedicines · doi:10.3390/biomedicines13020456 · Cited by 4
Baranašić, J., Šutić, M., Catalano, C., Drpa, G., Huhn, S., Majhen, D., Nestić, D., Kurtović, M., Rumora, L., Bosnar, M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092240 · Cited by 4
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential
He, J., Tan, H. Z., Qiu, Y., Dan, Y., Wan, Q., Li, L., Wu, J., Song, Q., Chen, H., & Xu, B. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101963 · Cited by 3
Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma
del Arco, C. D., Muñoz, L. E., Nieto, M. D. L. Á. C., Roldán, E. M., Fernández‐Aceñero, M. J., & Gómez‐Heras, S. G. (2024) · Biomedicines · doi:10.3390/biomedicines12071508 · Cited by 3
Relevance of the Human Microbiome in Breast Cancer: A Global Bibliometric and Visual Analysis
Javed, F., Ahmad, S., Issrani, R., Zeeshan, H. M., Iqbal, A., Syed, E., Alam, M. K., & Prabhu, N. (2024) · Scientifica · doi:10.1155/sci5/5518835 · Cited by 3
Chen, S., Zhu, S., PANG, S., Shi, H., Li, S., Liu, T., Li, M., Li, M., Guo, R., & He, Q. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114876 · Cited by 2
The human microbiome reshapes the breast cancer immune-metabolic-hormonal microenvironment
Wang, Q., 张富荣, Xin, Y., Yang, R., Tang, Z., Wu, Z., & Ming, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1774211 · Cited by 2
The interaction between microbes and cytokines in cancer: unraveling the underlying effects
Li, Y., Zhu, Y., Zhang, F., Huang, C. L., & Wang, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08174-2 · Cited by 2
Li, L., Yang, C., Wang, Z., Zhou, B., Zhang, Y., Liu, H. B., Sun, S., Chen, M., Hu, X., Jia, F., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.04.011 · Cited by 2
Toll-like receptors: versatile players in tumor
Yang, Y., & Pi, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735188 · Cited by 2
The role of microbiota and immune system crosstalk in cancer development and therapy
Behrouzi, A., Katebi, A., Riazi‐Rad, F., Mazaheri, H., & Ajdary, S. (2022) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2022.01650 · Cited by 2
Bacterial Darth Vader: May the force be with you
Polyák, K. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.008 · Cited by 2
Microbiome, immune system and cancer: three sides of the one medal
Belyavskaya, V. A., Чердынцева, Н. В., Kzhyshkowska, J. G., & Litvyakov, N. V. (2023) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2022-21-6-131-144 · Cited by 2
Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer
Yang, Y.-X., Jin, C., Yeo, A. E. T., & Jin, B. (2024) · Journal of Immunology Research · doi:10.1155/2024/1111551 · Cited by 2
Harnessing γδ T Cells against Human Gynecologic Cancers
Conejo-Garcia, J. R., Anadon, C. M., Lopez-Bailon, L. U., & Chaurio, R. A. (2024) · Life · doi:10.3390/life14030325 · Cited by 2
Self-citationZhou, Q., & Meng, Q. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58311-7_6 · Cited by 3
Therapeutic Implications of Angiogenesis in Cancer
Makhoul, I., Atrash, S., Arnaoutakis, K., Safar, M., Pennisi, A., Huffman, L. B., & Griffin, R. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-61115-0_9 · Cited by 2
Conejo-Garcia, J. R., & Rutkowski, M. R. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.014 · Cited by 2
Self-citationTamuli, B., Sharma, S., Patkar, M., & Biswas, S. (2024) · Cancer Reports · doi:10.1002/cnr2.2066 · Cited by 2
The Role of the Human Microbiome in Epithelial Ovarian Cancer
Mahoney, D. E. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58311-7_5 · Cited by 2
Ren, L., Suwanbai, M., Shi, L., Yan, S., Deng, C., Xie, W., Li, L., Yang, G., Wang, X., & Pan, X. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05126-4 · Cited by 1
Cortelette, N. A., Souza, N. D. O., Cataldi-Rodrigues, L., Arthur, C., Stowell, S. R., Dias-Baruffi, M., Guimarães, D. A. M., Ayres, L. R., & Pancoto, J. A. T. (2022) · Medicine · doi:10.1097/md.0000000000028489 · Cited by 1
γδ T cells: a sparkling star for clinical immunotherapy
Zheng, J., Jiang, X., Zhao, H., Wang, W., Wu, X., & Jin, Z. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00066 · Cited by 1
Immune State Conversion of the Mesenteric Lymph Node in a Mouse Breast Cancer Model
Shigehiro, T., Ueno, M., Kijihira, M., Takahashi, R., Umemura, C., Taha, E. A., Kurosaka, C., Asayama, M., Murakami, H., Satoh, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911035 · Cited by 1
Cancer and the science of innate immunity
Rutkowski, M. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00013-7 · Cited by 1
Self-citationKolli, S. H., McGinty, M. T., Lanfranca, M. P., Hatzinger, C. N., Putelo, A. M., Poblete, M. K., Bajgai, S., Thompson, B. A., Feng, T.-Y., Azar, F. N., et al. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf172 · Cited by 1
Self-citationClinical Connections Between the Microbiota and Breast Cancer (Onset, Progression and Management)
Filippone, A., & Magno, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00099-1 · Cited by 1
Atif, S. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_639 · Cited by 1
Immune responses to commensal bacteria
Alderton, G. K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3906
Innate Immune Receptors in the Regulation of Tumor Immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_25
Molecular Mechanisms of Tumor Dendritic Cell Dysfunction in Cancer
Tang, M. (2016) · TSpace (University of Toronto)
The Microbiota and Ovarian Cancer
Tanyi, J. L., & Facciabene, A. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_11
Chemoselective ligation assisted DNA walker for analysis of double targets
Xue, T., Longfei, T., Yue, X., Niu, L., Peng, J., & Zhang, J. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111620
Bach, C. A., Cutine, A. M., Laporte, L., Mahmoud, Y. D., Cocco, M. N. M., Massaro, M., Merlo, J. P., Perrotta, R. M., Sarbia, N., Veigas, F., et al. (2020) · Science Reviews - from the end of the world · doi:10.52712/sciencereviews.v2i1.32
Self-citationAtwa, H. A., Samy, W. M., Abdelhamid, M. I., & Elaidy, N. F. (2021) · Revista de Senología y Patología Mamaria · doi:10.1016/j.senol.2021.06.002
Circulating biomarkers and prognosis in colorectal cancer
Gunawardene, A. R. (2021) · Otago University Research Archive (University of Otago)
Wang, X., Zhang, Y., & Liu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-1073003/v1
Marabelle, A., & Gray, J. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-43486-5_13
Dutt, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732882487.793545488
Atif, S. M. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_639-1
Yazykova, A. B., Владимировна, М. И., Власов, М. В., Vvedenskiy, P. S., & Lebedev, M. Y. (2022) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2022.107012
Rodríguez-Corona, J. M., Garrido, R. R.-E., Horta‐Vega, J. V., & Velázquez-Flores, M. Á. (2022) · Research Square · doi:10.21203/rs.3.rs-1462683/v1
Miller, K. D., Pniewski, K. A., Perry, C. E., Papp, S. B., Shaffer, J. D., Velasco‐Silva, J. N., Casciano, J. C., Aramburu, T. M., Srikanth, Y. V. V., Cassel, J. A., et al. (2023) · doi:10.1158/0008-5472.c.6512743.v1
Perales‐Puchalt, A., Svoronos, N., Rutkowski, M. R., Allegrezza, M. J., Tesone, A. J., Payne, K. K., Wickramasinghe, J. M., Nguyen, J. M., O’Brien, S. W., Gumireddy, K., et al. (2023) · doi:10.1158/1078-0432.22467855.v1
Self-citationPerales‐Puchalt, A., Svoronos, N., Rutkowski, M. R., Allegrezza, M. J., Tesone, A. J., Payne, K. K., Wickramasinghe, J. M., Nguyen, J. M., O’Brien, S. W., Gumireddy, K., et al. (2023) · doi:10.1158/1078-0432.22467855
Self-citationGut Microbiota and Host Immune System in Cancer
Sunita, P., Pattanayak, S. P., Ranjan, G., & Bose, P. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030004
Intracellular microbiome in oral cancer progression
Ganapathy, D. M., Sekaran, S., & Ramasamy, P. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100368
Galektin-1 indukált T sejt apoptózis vizsgálatok
Novák, J. (2023) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11666
Inflammation Resolution Mediators: Future Prospects
Müller, R. L. J., Hoch, M., & Gupta, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-0157-5_9
Al-Marsomy, H. D., Mouhammed, K., Al-Baldawy, A. N., & Mohammed, N. H. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.273
Gut Microbiota, Breast Cancer, and Neoadjuvant Therapy
夏, 晨. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153606
Metadata
- Authors
- Rutkowski, M. R., Stephen, T. L., Svoronos, N., Allegrezza, M. J., Tesone, A. J., Perales-Puchalt, A., Brencicova, E., Escovar-Fadul, X., Nguyen, J. M., Cadungog, M. G., Zhang, R., Salatino, M., Tchou, J., Rabinovich, G. A., & Conejo-Garcia, J. R.
- Affiliations
- The Wistar Institute (US)
- Christiana Care Health System (US)
- University of Pennsylvania (US)
- Abramson Cancer Center (US)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- Conejo-Garcia, Jose R.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 27
- Issue
- 1
- Pages
- 27-40
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4293269
- OpenAlex
- W2164918734
- Cited by
- 311
- References
- 28
- Citations by year
- 2026: 13 · 2025: 28 · 2024: 24 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 35 · 2016: 35 · 2015: 16
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Conicet (submittedVersion, cc-by-nc-sa)
- Funders
- National Cancer Institute (CA010815, R01CA157664, U54CA151662, R01CA178687, R01CA163377, R01CA124515, T32CA009171, P30CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- TLR5, flagellin, commensal bacteria, tumor-promoting inflammation, myeloid-derived suppressor cells, granulocytic MDSCs, γδ T cells, galectin-1, interleukin-6, IL-17, antitumor immunity, malignant progression, ovarian cancer, breast cancer, microbiome
- MeSH terms
- Animals, Cells, Cultured, Humans, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Neoplasm Transplantation, Neoplasms, Signal Transduction, Interleukin-6, Gene Expression Regulation, Neoplastic, Interleukin-17, Polymorphism, Single Nucleotide, Galectin 1, Cell Line, Tumor, Toll-Like Receptor 5, Mice, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
